메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
Mohammed Solayman Hossain (Soonchunhyang University) Hoonhee Seo (Soonchunhyang University) Md Abdur Rahim (Soonchunhyang University) Md Sarower Hossen Shuvo (Soonchunhyang University) Indrajeet Barman (Soonchunhyang University) Hokyoung Kim (Soonchunhyang University) Jinhyeon An (Soonchunhyang University) Sukyung Kim (Soonchunhyang University) Ho-Yeon Song (Soonchunhyang University)
저널정보
대한미생물학회 JOURNAL OF BACTERIOLOGY AND VIROLOGY JOURNAL OF BACTERIOLOGY AND VIROLOGY Vol.54 No.4
발행연도
2024.12
수록면
325 - 342 (18page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Tuberculosis (TB) remains a global health crisis, with the emergence of multidrug-resistant strains necessitating the development of novel therapeutic strategies.
Approximately one-fourth of the world’s population, or 2 billion people, are infected with latent TB. The rise of multidrug-resistant (MDR), extensively drug-resistant (XDR), and totally drug-resistant (TDR) strains of Mycobacterium tuberculosis (M. tb) poses a significant threat, reducing the effectiveness of conventional treatments. The limitations of current antibiotic regimens underscore the urgent need for alternative approaches. This highlights the urgent need for new anti-tuberculosis drugs. Probiotics, known for their health benefits against various infections, may offer a promising alternative in combating antibiotic-resistant TB. This study aimed to identify novel probiotic strains with anti-tuberculosis potential. Seven probiotic strains were selected by screening with the GFP-TB in vitro model. Treatment with probiotic extracts significantly reduced the TB burden inside macro- phage cells analyzed by confocal microscopy, ranging from 51% to 76%. The anti-tuberculosis efficacy of these candidate strains was further evaluated using CFU and resazurin assay s, where treatment with probiotics resulted in up to a 1.25 log reduction of viable TB in the CFU assay. To ensure the probiotic strains were safe for therapeutic application, comprehensive safety assessments were conducted, including evaluations of cytotoxicity, antibiotic susceptibility test, hemolysis, bile salt deconjugation, and D-lactate assay. Following the safety confirmation, we investigated the underlying mechanisms by which these probiotic strains enhance immunity and facilitate the clearance of TB within macrophage cells in vitro. This involved assessing autophagy gene expression and nitrite reduction, which are established methods for studying anti-tuberculosis effects. The results of these mechanistic studies align with the CFU and confocal microscopy findings, indicating that at least three of the probiotic strains have the potential to mitigate tuberculosis infection significantly. This research provides a foundation for further exploration of these probiotic strains as potential biotherapeutics in tuberculosis treatment. However, further studies on toxicity, mechanism of action, and efficacy in animals, followed by clinical trials, are necessary.

목차

INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSION
REFERENCES

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-151-25-02-092172229